These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 9146780)
1. Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome. Schütze K; Brandstätter G; Dragosics B; Judmaier G; Hentschel E Aliment Pharmacol Ther; 1997 Apr; 11(2):387-94. PubMed ID: 9146780 [TBL] [Abstract][Full Text] [Related]
2. "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. Van Outryve M; Milo R; Toussaint J; Van Eeghem P J Clin Gastroenterol; 1991 Feb; 13(1):49-57. PubMed ID: 2007745 [TBL] [Abstract][Full Text] [Related]
3. The symptomatic effect of cisapride in patients with irritable bowel syndrome and constipation. Farup PG; Hovdenak N; Wetterhus S; Lange OJ; Hovde O; Trondstad R Scand J Gastroenterol; 1998 Feb; 33(2):128-31. PubMed ID: 9517521 [TBL] [Abstract][Full Text] [Related]
4. Effects of cisapride on symptoms and postcibal small-bowel motor function in patients with irritable bowel syndrome. Noor N; Small PK; Loudon MA; Hau C; Campbell FC Scand J Gastroenterol; 1998 Jun; 33(6):605-11. PubMed ID: 9669632 [TBL] [Abstract][Full Text] [Related]
5. Effects of oral cisapride on small bowel motility in irritable bowel syndrome. Evans PR; Bak YT; Kellow JE Aliment Pharmacol Ther; 1997 Oct; 11(5):837-44. PubMed ID: 9354190 [TBL] [Abstract][Full Text] [Related]
6. Cisapride treatment of constipation-predominant irritable bowel syndrome is not superior to placebo. Ziegenhagen DJ; Kruis W J Gastroenterol Hepatol; 2004 Jul; 19(7):744-9. PubMed ID: 15209619 [TBL] [Abstract][Full Text] [Related]
7. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group. Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812 [TBL] [Abstract][Full Text] [Related]
9. Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Müller-Lissner SA; Fumagalli I; Bardhan KD; Pace F; Pecher E; Nault B; Rüegg P Aliment Pharmacol Ther; 2001 Oct; 15(10):1655-66. PubMed ID: 11564007 [TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic constipation with cisapride and placebo. Müller-Lissner SA Gut; 1987 Aug; 28(8):1033-8. PubMed ID: 3311905 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Novick J; Miner P; Krause R; Glebas K; Bliesath H; Ligozio G; Rüegg P; Lefkowitz M Aliment Pharmacol Ther; 2002 Nov; 16(11):1877-88. PubMed ID: 12390096 [TBL] [Abstract][Full Text] [Related]
12. Use of cisapride in treatment of constipation in children. Odeka EB; Sagher F; Miller V; Doig C J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):199-203. PubMed ID: 9252908 [TBL] [Abstract][Full Text] [Related]
13. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial. Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995 [TBL] [Abstract][Full Text] [Related]
14. Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation. Chang L; Chey WD; Drossman D; Losch-Beridon T; Wang M; Lichtlen P; Mareya S Aliment Pharmacol Ther; 2016 Nov; 44(10):1114-1122. PubMed ID: 27669680 [TBL] [Abstract][Full Text] [Related]
15. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions. Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191 [TBL] [Abstract][Full Text] [Related]
16. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437 [TBL] [Abstract][Full Text] [Related]
17. Effect of cisapride on chronic idiopathic constipation in children. Staiano A; Cucchiara S; Andreotti MR; Minella R; Manzi G Dig Dis Sci; 1991 Jun; 36(6):733-6. PubMed ID: 2032513 [TBL] [Abstract][Full Text] [Related]
18. Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients. Wood SF; Penney SC; Cochran KM Scand J Gastroenterol Suppl; 1993; 195():5-10. PubMed ID: 8516659 [TBL] [Abstract][Full Text] [Related]
19. Cisapride in neurologically impaired children with chronic constipation. Staiano A; Del Giudice E; Simeone D; Miele E; Marino A Dig Dis Sci; 1996 May; 41(5):870-4. PubMed ID: 8625757 [TBL] [Abstract][Full Text] [Related]
20. Cisapride in chronic idiopathic constipation: clinical response and effect on colonic transit time. Bak YT; Kim JH; Lee CH Korean J Intern Med; 1996 Jun; 11(2):151-6. PubMed ID: 8854652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]